Faculty Opinions recommendation of Efficacy and safety of intra-articular injection of tropomyosin receptor kinase A inhibitor in painful knee osteoarthritis: a randomized, double-blind and placebo-controlled study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.736280654.793573711 ◽

2020 ◽

Author(s):

Susanne Grässel

Keyword(s):

Knee Osteoarthritis ◽

Controlled Study ◽

Receptor Kinase ◽

Efficacy And Safety ◽

Double Blind ◽

Painful Knee ◽

Kinase A

Download Full-text

Efficacy and safety of intra-articular injection of tropomyosin receptor kinase A inhibitor in painful knee osteoarthritis: a randomized, double-blind and placebo-controlled study

Osteoarthritis and Cartilage ◽

10.1016/j.joca.2019.05.028 ◽

2019 ◽

Vol 27 (11) ◽

pp. 1599-1607 ◽

Cited By ~ 8

Author(s):

E. Krupka ◽

G.-L. Jiang ◽

C. Jan

Keyword(s):

Knee Osteoarthritis ◽

Controlled Study ◽

Receptor Kinase ◽

Efficacy And Safety ◽

Double Blind ◽

Painful Knee ◽

Kinase A

Download Full-text

326 A MULTICENTRE, INTERNATIONAL, DOUBLE BLIND, RANDOMIZED, PLACEBO – CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF 2 DIFFERENT REGIMENS OF HYADD4-G IN KNEE OSTEOARTHRITIS

Osteoarthritis and Cartilage ◽

10.1016/s1063-4584(10)60353-6 ◽

2010 ◽

Vol 18 ◽

pp. S144 ◽

Cited By ~ 3

Author(s):

K. Pavelka ◽

F.U. Niethard ◽

N. Giordan

Keyword(s):

Knee Osteoarthritis ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind

Download Full-text

A phase 2, randomized, double-blind, placebo-controlled study of senolytic molecule UBX0101 in the treatment of painful knee osteoarthritis

Osteoarthritis and Cartilage ◽

10.1016/j.joca.2021.02.077 ◽

2021 ◽

Vol 29 ◽

pp. S52-S53

Author(s):

N. Lane ◽

B. Hsu ◽

J. Visich ◽

B. Xie ◽

A. Khan ◽

...

Keyword(s):

Knee Osteoarthritis ◽

Controlled Study ◽

Phase 2 ◽

Double Blind ◽

Double Blind Placebo ◽

Painful Knee

Download Full-text

The efficacy, safety and carry-over effect of diacerein in the treatment of painful knee osteoarthritis: a randomised, double-blind, NSAID-controlled study

Osteoarthritis and Cartilage ◽

10.1016/j.joca.2007.02.021 ◽

2007 ◽

Vol 15 (6) ◽

pp. 605-614 ◽

Cited By ~ 34

Author(s):

W. Louthrenoo ◽

S. Nilganuwong ◽

S. Aksaranugraha ◽

P. Asavatanabodee ◽

S. Saengnipanthkul ◽

...

Keyword(s):

Knee Osteoarthritis ◽

Controlled Study ◽

Double Blind ◽

Carry Over ◽

Painful Knee ◽

Carry Over Effect

Download Full-text

Mo1540 THE EFFICACY AND SAFETY OF GCWB104 (FLOS LONICERA EXTRACT) IN FUNCTIONAL DYSPEPSIA: A SINGLE-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

Gastroenterology ◽

10.1016/s0016-5085(20)32906-1 ◽

2020 ◽

Vol 158 (6) ◽

pp. S-887-S-888

Author(s):

Nayoung Kim ◽

Yonghoon Choi ◽

Dong Ho Lee

Keyword(s):

Functional Dyspepsia ◽

Controlled Study ◽

Efficacy And Safety ◽

Single Center ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of Lidocaine Infusion Treatment for Neuropathic Pain: A Randomized, Double-Blind, and Placebo Controlled Study

10.26226/morressier.5ab3c87fa874c60026558c0a ◽

2018 ◽

Author(s):

Jae-kyu Choi

Keyword(s):

Neuropathic Pain ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725732407.793547378 ◽

2018 ◽

Author(s):

Maria Laura Bertolaccini

Keyword(s):

Systemic Lupus Erythematosus ◽

Monoclonal Antibody ◽

Lupus Erythematosus ◽

Phase Iii ◽

Controlled Study ◽

Efficacy And Safety ◽

Systemic Lupus ◽

Double Blind ◽

Double Blind Placebo ◽

B Cell Activating Factor

Download Full-text

Faculty Opinions recommendation of Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter, placebo-controlled study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.731185224.793557190 ◽

2019 ◽

Author(s):

Felice Petraglia ◽

Silvia Vannuccini

Keyword(s):

Controlled Study ◽

Efficacy And Safety ◽

Double Blind

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of the first-in-class imidazoline-2 receptor ligand CR4056 in pain from knee osteoarthritis and disease phenotypes: a randomized, double-blind, placebo-controlled phase 2 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.736628903.793573715 ◽

2020 ◽

Author(s):

Susanne Grässel

Keyword(s):

Knee Osteoarthritis ◽

Phase 2 ◽

Efficacy And Safety ◽

Double Blind ◽

Receptor Ligand ◽

Double Blind Placebo ◽

Disease Phenotypes ◽

Phase 2 Trial

Download Full-text

Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of AS-013, a Prostaglandin E1Prodrug, in Patients With Intermittent Claudication

Circulation ◽

10.1161/01.cir.95.9.2298 ◽

1997 ◽

Vol 95 (9) ◽

pp. 2298-2302 ◽

Cited By ~ 59

Author(s):

J.J.F. Belch ◽

P.R.F. Bell ◽

D. Creissen ◽

J.A. Dormandy ◽

R.C. Kester ◽

...

Keyword(s):

Intermittent Claudication ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text